Mefloquine

Edina Avdic, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS

INDICATIONS

FDA

  • Treatment of mild to moderate acute malaria (P. falciparum and P. vivax) caused by chloroquine-resistant, chloroquine-susceptible and multiple-drug-resistant (including sulfadoxine and pyrimethamine-resistant) strains
  • Malaria (P. falciparum and P. vivax) prophylaxis including prophylaxis of chloroquine-resistant strains of P. falciparum.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 10, 2021